TPN171H
Sponsors
Vigonvita Life Sciences
Conditions
Erectile DysfunctionPulmonary Arterial Hypertension
Phase 1
Study of the Pharmacokinetics and Safety of TPN171H Tablets in Subjects With Mild ,Moderate Hepatic Insufficiency and Normal Liver Function
CompletedNCT05185011
Start: 2021-12-16End: 2022-02-06Updated: 2022-03-23
The Safety, Tolerability, and Pharmacokinetics of TPN171H Tablets in Patients With Pulmonary Arterial Hypertension
CompletedNCT05948644
Start: 2019-04-08End: 2020-10-14Updated: 2023-10-13
Safety and Pharmacokinetics of a Single Oral TPN171H in Healthy Elderly Subjects
CompletedNCT06090136
Start: 2020-09-14End: 2022-07-22Updated: 2023-10-19
Drug-Drug Interaction (DDI) Study for TPN171H
CompletedNCT06090123
Start: 2020-01-01End: 2020-09-02Updated: 2023-10-19